Cyclophosphamide drug study
WebJul 19, 2024 · Brief Summary: This study is to investigate the strategy of biomarker guided treatment in diffuse large B cell lymphoma Study Design Go to Resource links provided by the National Library of Medicine Genetic and Rare Diseases Information Center resources: B-cell Lymphoma Lymphosarcoma Diffuse Large B-Cell Lymphoma U.S. FDA Resources WebJun 13, 2014 · Patient has received rituximab (or a rituximab biosimilar), cyclophosphamide, or vincristine. Patient has allergies or hypersensitivity to murine, chimeric, human or humanised proteins, cyclophosphamide, vincristine, or prednisone. Patient has evidence of histological transformation to high-grade or diffuse large B-cell …
Cyclophosphamide drug study
Did you know?
WebActive Comparator: R-CHOP. Patients in R-CHOP group will receive rituximab 375 mg/m² IV on day 1, cyclophosphamide 750 mg/m² IV, doxorubicin 50 mg/m² iv, and vincristine … WebApr 1, 2024 · Descriptions. Cyclophosphamide is used to treat cancer of the ovaries, breast, blood and lymph system, and nerves (mainly in children). Cyclophosphamide is …
WebA number of agents have been evaluated as treatments for scleroderma-related interstitial lung disease, but none have been proven effective. 3 Only cyclophosphamide has shown promise in several... WebCyclophosphamide is an anticancer drug that reduces sperm counts as well as cause an absence of spermatogenic cycles in the testicular tissue, injures progeny, decreases the …
WebAug 15, 2024 · Cyclophosphamide Last Revision: August 15, 2024. Estimated reading time: 4 minutes CASRN: 50-18-0 Go to: Drug Levels and Effects Summary of Use during Lactation Cyclophosphamide appears … WebJul 29, 2024 · Study Description Go to Brief Summary: This phase I trial tests the safety and side effects of cyclophosphamide given together with dexamethasone in treating patients with castration resistant prostate cancer that has spread to other places in …
WebNov 3, 2024 · GCC2024 is a prospective open-label phase 1 trial to determine the best safe dose of ibrutinib to use in combination with a previously studied chemo-immunotherapy regimen, comprised of the IDO-inhibitor indoximod plus oral metronomic cyclophosphamide and etoposide (4-drug combination) for participants, age 12 to 25 …
WebIt is a chemotherapy drug that works by slowing or stopping cell growth.Cyclophosphamide also works by decreasing your immune system's response … terme topliceWebSummary Dacarbazine is an antineoplastic agent used to treat malignant melanoma and Hodgkin's disease. Generic Name Dacarbazine DrugBank Accession Number DB00851 Background An antineoplastic agent. It has significant activity against melanomas. (from Martindale, The Extra Pharmacopoeia, 31st ed, p564). triceps enthesopathy icd 10WebMay 22, 2024 · 1703: The study is designed as a randomized, phase III, multicenter trial comparing two acute graft-versus-host disease (aGVHD) prophylaxis regimens: tacrolimus/methotrexate (Tac/MTX) versus post-transplant cyclophosphamide/tacrolimus/mycophenolate mofetil (PTCy/Tac/MMF) in the setting of … terme tombolotermet pompa ciepła heat gold 12 dcWebMar 17, 2024 · The purpose of this study is to assess the safety and tolerability of epcoritamab in combination with anti-neoplastic agents in adult participants with Non-Hodgkin lymphoma (NHL). Adverse events and change in disease activity will be assessed. Epcoritamab is an investigational drug being developed for the treatment of NHL. triceps em inglesWebFeb 10, 2024 · INTRODUCTION. Cyclophosphamide (CYC), an alkylating agent, is one of the most potent immunosuppressive therapies available. It has been used extensively to … triceps et biceps brachialWebMay 17, 2024 · Study Description Go to Brief Summary: A multi-centre phase II trial of GvHD prophylaxis following unrelated donor stem cell transplantation comparing Thymoglobulin vs. Calcineurin inhibitor or Sirolimus-based post-transplant cyclophosphamide. Show detailed description Study Design Go to Resource links … triceps elbow pain